PepDiana
Back to Evidence
Primary experimental recordNegative / threshold

PMC13133793::ACT044558

LCKLSL

Evidence text

Paper-level observation

Quantitative analysis demonstrated equivalent retinal thickness measurements between treatment and control groups (p>0.05) (Figure 2C).
textConfidence: medium

Assay observation

Activity
Toxicity
Subtype
General Toxic
Measure
other
Comparator
>
Raw observation
equivalent retinal thickness measurements between treatment and control groups (p>0.05)
Normalized measurement
>0.05
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Mus musculus
Assay method
Not reported by source
Sequence
LCKLSL
Standardization
ready simple

Source publication

Study on the Role of Short Peptide LCKLSL Targeting ANXA2 in Retinal Neovascularization.

In Vivo · 2026

DOI 10.21873/invivo.14291 PMC13133793
Parent mention

Related peptide identities

PEPDIA-PLP-001707

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.